Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [I-125]7-OH-PIPAT: Evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals
Gd. Stanwood et al., Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [I-125]7-OH-PIPAT: Evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals, J PHARM EXP, 295(3), 2000, pp. 1223-1231
Citations number
48
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
The regional distribution and cellular localization of dopamine D3 receptor
s in the rat brain was examined using quantitative autoradiography. [I-125]
7-OH-PIPAT bound in a saturable and reversible manner and exhibited subnano
molar affinity for a single population of GTP-insensitive sites. The pharma
cological profile was characteristic of cloned D3 receptors and nonspecific
binding was uniformly low. The highest levels of D3 receptors were measure
d in the islands of Calleja, nucleus accumbens, ventral pallidum, substanti
a nigra, and lobules 9 and 10 of the cerebellum. The high specific activity
of this ligand also allowed detection of D3 receptors in other regions, in
cluding the serotonergic dorsal and median raphe nuclei, indicating that th
e distribution of this receptor is more widespread than previously apprecia
ted. The cellular localization of D3 receptors in regions containing dopami
nergic cells and terminals was examined by discrete injection of neurotoxin
s. Lesion of dopaminergic neurons with 6-hydroxydopamine produced 50% decre
ases in [I-125]7-OH-PIPAT binding in the nucleus accumbens and substantia n
igra. Quinolinic acid lesion of neurons originating in the nucleus accumben
s also produced approximately 50% decreases in D3 receptors in the nucleus
accumbens, substantia nigra, and ventral pallidum. 5,7-Dihydroxytryptamine
lesion of serotonergic cells and processes produced no changes in [I-125]7-
OH-PIPAT binding. These results demonstrate the presence of D3 receptors in
several brain regions not previously identified and suggest that D3 recept
ors are expressed at somatodendritic and terminal levels of both dopaminerg
ic and nondopaminergic cells within the mesolimbic dopamine system.